357 results about "INFERTILITY MALE" patented technology

The invention relates to a corning pill which comprises plantain seed, fringed pink, polygonum aviculare, soapstone, earthworm, seaweed, laminaria, pangolin, red flower, peach kernel, honeysuckle, cordate houttuynia, gardenia, scutellaria baicalensis, agilawood, fructus amomi, cowherb seed, elecampane, mangnolia officinalis and fructus aurantii. The corning pill has the major functions of treatingmale genitourinary system diseases including male infertility, prostatitis, orchitis, seminal vesiculitis, male and female urethritis, cystitis and the like.

The invention provides a kit for male azoospermia diagnosis and a use method. The kit contains biological marker detection reagents for measuring different expression levels of plasma miR-15b, and azoospermia is prompted by excessive expression of the miR-15b. Tiny RNA (ribonucleic acid) genes miR-15b playing an important role in the sperm generation process are discovered, the miR-15b is differently expressed in male infertility patients, and significant expression change of the miR-15b can be detected in the plasma. Based on the principle of quantitative PCR (polymerase chain reaction), and the kit is fine in result repeatability, objective, accurate and easily popularized in different detection mechanisms, hospital laboratories, male laboratories and the like.

The invention provides a method for detecting neuraminidase influencing sperm functions. The method is a novel laboratory detecting method for assessing quality and functions of a sperm and can provide detection and clinical consultations for male infertility patients without clear clinical reasons for infertility. The method is characterized in that expressions of neuraminidase in the sperm are visually quantized through single sperm fluorescence strength analysis or are visually observed by means of fluorescence imaging under a microscope, and if the neuraminidase is highly expressed in the sperm, capacitation of the sperm is achieved through external capacitation liquid, and neuraminidase activity is detected in a fluorescence method.

The invention relates to a composite traditional Chinese preparation medicine for treating male infertility, impotence and premature ejaculation and a preparation method thereof, and in particular relates to a yang-tonifying traditional Chinese medicine for generating and strengthening sperms, which is prepared by a plurality of plant Chinese medicines and less animal traditional Chinese medicines as materials for treating the diseases such as aspermia, oligospermia, weak sperm, teratospermia, non-liquefied semen, impotence, premature ejaculation and sexual dysfunction in male infertility, belonging to the technical field of traditional Chinese medicine production. The yang-tonifying traditional Chinese medicine is prepared by the following materials in parts by weight: 0.5-1.5 parts of bloody velvet deer antler, 5-10 parts of morinda officinalis, 6-12 parts of Chinese yam, 5-10 parts of fruit of Chinese wolfberry, 5-10 parts of cortex moutan, 5-15 parts of radix rehmanniae preparata, 5-10 parts of pulp of dogwood fruit, 5-15 parts of poria, 5-10 parts of rhizoma alismatis, 5-15 parts of cuscutaceae, 5-10 parts of raspberry, 2-6 parts of rhizoma curculiginis, 5-10 parts of herba epimedii and 2-10 parts of schisandra chinensis. Water is directly added to the components for boiling the mixture to be decoction, or crushing and mixing the components into powder, capsules or pills. The yang-tonifying traditional Chinese medicine provided by the invention has a simple preparation process, a remarkable effect, no toxic or side effect, an effective rate of 100%, a cure rate of 85% of after being taken for one month, and a curate rate of 91% after being taken for two months.

The diagnosis of male infertility is based predominantly on the results of standard semen analysis for concentration, total motility, progressive motility, volume, pH, viscosity and / or morphology. When sperm enter the female reproductive tract, they must undergo a series of physiological changes, known as capacitation, in order to fertilize an egg. This process involves plasma membrane changes that occur in response to stimuli within the female tract. These changes include removal of sterols and redistribution of the ganglioside GM1. Semen analysis identifies only half the cases of male infertility due to standard semen analysis providing little information on sperm functional competence. Previous data demonstrated that localization of the ganglioside, GM1, identifies sub-populations of sperm capable of undergoing the functional maturation process known as capacitation and tracks strongly with fertility.